ConductScience.org, home

Paper39652176

Treatment of cancer-associated fibroblast-like cells with celecoxib enhances the anti-cancer T helper 1/Treg responses in breast cancer.

Samoudi A and 5 others. Naunyn Schmiedebergs Arch Pharmacol, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Treatment of cancer-associated fibroblast-like cells with celecoxib enhances the anti-cancer T helper 1/Treg responses in breast cancer. Papers, record 39652176. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39652176

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of cancer-associated fibroblast-like cells with celecoxib enhances the anti-cancer T helper 1/Treg responses in breast cancer.
PubMed
Journal
Naunyn Schmiedebergs Arch Pharmacol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-11-02
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Samoudi AArash
2Abolhasani-Zadeh FFiroozeh
3Afgar AAli
4Jalilian EElnaz
5Zeinalynezhad HHamid
6Langroudi LLadan

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CelecoxibMajor topic
Breast NeoplasmsMajor topic
Cancer-Associated FibroblastsMajor topic
Cyclooxygenase 2 InhibitorsMajor topic
T-Lymphocytes, RegulatoryMajor topic
Th1 CellsMajor topic
Antineoplastic AgentsMajor topic
Humans
Female
Cytokines
Cyclooxygenase 2
Middle Aged
Dinoprostone
Tumor Microenvironment
Coculture Techniques

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
IR.KMU.REC.1398.257Kerman univPubMed

Source PubMed

Download CSV of grants

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17836930Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.J Exp Med1995https://conductscience.org/library/papers/7836930PubMed
230140269Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation.Front Immunol2018https://conductscience.org/library/papers/30140269PubMed
332810447The tumor microenvironment.Curr Biol2020https://conductscience.org/library/papers/32810447PubMed
428096371COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28096371PubMed
51845802Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines.J Immunol1991https://conductscience.org/library/papers/1845802PubMed
629483289Prostaglandin E2 Induction Suppresses the Th1 Immune Responses in Cattle with Johne's Disease.Infect Immun2018https://conductscience.org/library/papers/29483289PubMed
78759715Bcl-2 expression inhibits prostaglandin E2-mediated apoptosis in B cell lymphomas.J Immunol1996https://conductscience.org/library/papers/8759715PubMed
834445735Failure of Immunotherapy-The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer.Int J Mol Sci2021https://conductscience.org/library/papers/34445735PubMed
931838289New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.Bioorg Chem2020https://conductscience.org/library/papers/31838289PubMed
1028231855COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.J Transl Med2017https://conductscience.org/library/papers/28231855PubMed
1116996805Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia.Clin Gastroenterol Hepatol2006https://conductscience.org/library/papers/16996805PubMed
1217483367Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.Cancer Res2007https://conductscience.org/library/papers/17483367PubMed
1327375620Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells - Role of Anchored Protein Kinase A Signaling Units.Front Immunol2016https://conductscience.org/library/papers/27375620PubMed
1421907301COX-2 and PGE2-dependent immunomodulation in breast cancer.Prostaglandins Other Lipid Mediat2011https://conductscience.org/library/papers/21907301PubMed
1511278747Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice.J Biol Chem2001https://conductscience.org/library/papers/11278747PubMed
1635675777PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment.Cell Rep2022https://conductscience.org/library/papers/35675777PubMed
1721376230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
1834178680The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition.Front Oncol2021https://conductscience.org/library/papers/34178680PubMed
1919136477The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.Carcinogenesis2009https://conductscience.org/library/papers/19136477PubMed
2022534817Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer.J Thorac Oncol2012https://conductscience.org/library/papers/22534817PubMed

See all 66 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
41890735Aging modulation of the immune system and immunotherapy efficacy in cancer.Front Immunol2026https://conductscience.org/library/papers/41890735PubMed
41383482Celecoxib in oncology: targeting the COX-2/PGE2 axis to reprogram the tumor immune microenvironment and enhance multimodal therapy.Front Pharmacol2025https://conductscience.org/library/papers/41383482PubMed
40551209Paracrine signaling in cancer-associated fibroblasts: central regulators of the tumor immune microenvironment.J Transl Med2025https://conductscience.org/library/papers/40551209PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39652176

GET https://conductscience.org/api/papers/v1/39652176/references?page=2